LMAT
LeMaitre Vascular, Inc. Healthcare - Medical Instruments & Supplies Investor Relations →
LeMaitre Vascular, Inc. (LMAT) closed at $112.04 as of 2026-05-01, trading 55.2% above its 200-week moving average of $72.19. The stock is currently moving closer to the line, down from 57.9% last week. With a 14-week RSI of 87, LMAT is in overbought territory.
Trading volume is running at 1.1x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.86 ratio) is neutral — neither side is clearly dominating.
Over the past 971 weeks of data, LMAT has crossed below its 200-week moving average 4 times. On average, these episodes lasted 34 weeks. Historically, investors who bought LMAT at the start of these episodes saw an average one-year return of +33.2%.
With a market cap of $2.6 billion, LMAT is a mid-cap stock. The company generates a free cash flow yield of 1.9%. Return on equity stands at 15.8%, a solid level. The stock trades at 6.5x book value.
Share count has increased 3.1% over three years, indicating dilution. LMAT passes our Buffett quality screen: high return on equity, low debt, and positive free cash flow.
Over the past 18.7 years, a hypothetical investment of $100 in LMAT would have grown to $1777, compared to $666 for the S&P 500. That represents an annualized return of 16.7% vs 10.7% for the index — confirming LMAT as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been growing at a 49.8% compound annual rate, with 4 consecutive years of positive cash generation.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: LMAT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After LMAT Crosses Below the Line?
Across 4 historical episodes, buying LMAT when it crossed below its 200-week moving average produced an average return of +30.0% after 12 months (median +59.0%), compared to +10.2% for the S&P 500 over the same periods. 75% of those episodes were profitable after one year. After 24 months, the average return was +42.5% vs +28.2% for the index.
Each line shows $100 invested at the moment LMAT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
LMAT has crossed below its 200-week MA 4 times with an average 1-year return of +33.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Dec 2007 | Nov 2009 | 100 | 62.0% | -63.7% | +2132.9% |
| Mar 2010 | Apr 2010 | 2 | 2.4% | +52.9% | +2903.9% |
| Dec 2018 | Feb 2019 | 8 | 4.4% | +61.0% | +440.8% |
| Feb 2020 | Aug 2020 | 26 | 25.6% | +82.6% | +318.1% |
| Average | 34 | — | +33.2% | — |
Frequently Asked Questions
Is LMAT below its 200-week moving average?
No. LeMaitre Vascular, Inc. (LMAT) is currently 55.2% above its 200-week moving average of $72.19. It would need to fall to $72.19 to cross below the line.
What is LMAT's 200-week moving average price?
LeMaitre Vascular, Inc.'s 200-week moving average is $72.19 as of 2026-05-01. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when LMAT drops below its 200-week moving average?
LMAT has crossed below its 200-week moving average 4 times in our data. On average, buying at that moment produced a one-year return of +33.2%. These dips have historically been decent entry points. These episodes lasted 34 weeks on average.
Is LMAT a good value right now?
Here's what our data says about LMAT as of 2026-05-01: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 87 (overbought). Free cash flow yield is 1.9%. Return on equity is 15.8%. Price-to-book is 6.5x. This is not a buy or sell recommendation — always do your own research.
How does LMAT compare to the S&P 500?
Over the past 18.7 years, $100 invested in LMAT would have grown to $1777, compared to $666 for the S&P 500. That's 16.7% annualized vs 10.7% for the index. LMAT has outperformed the broader market over this period.
Does LMAT pay a dividend?
Yes. LeMaitre Vascular, Inc. currently pays a dividend yield of 89.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-05-01